Three new EU-TOPIA publications: Systematically graded evidence on the present benefits of screening for cervical, breast and colorectal cancer screening in 4 European regions
In three respective papers, the EU-TOPIA project has reviewed all European published reports on the impact of screening on disease specific mortality. Various evaluations of benefits of screening have taken place in the past, but those were often lacking a uniform grading of the evidence, were country-specific, or not related to the primary outcome measure of cancer specific mortality decline. With the recently published results in the Erupean Journal of Cancer, we provide region-specific best-practice benchmarking.
The most important messages are that 1) all 3 site specific programmes result in substantial cancer mortality reductions in those parts of Europe where screening is implemented and monitored, and 2) cancer mortality reductions due to screening are more consistent throughout European regions than might have been expected. Therefore, these reviews are essential for benchmarking quality of screening and subsequent care in the region, and enabling neighbouring countries through use of their own data to assess its performance regularly and in time.
All three papers are published in the European Journal of Cancer and are open access: